-
$2,000 Read More Botulism – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Botulism - Pipeline Review, H1 2016’, provides an overview of the Botulism pipeline landscape. The report provides comprehensive information on the therapeutics under development for Botulism, complete with analysis by stage of development, drug target, mechanism of acti... -
$2,000 Read More Cholera – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Cholera - Pipeline Review, H1 2016’, provides an overview of the Cholera pipeline landscape. The report provides comprehensive information on the therapeutics under development for Cholera, complete with analysis by stage of development, drug target, mechanism of action ... -
$2,000 Read More Typhoid Fever – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Typhoid Fever - Pipeline Review, H1 2016’, provides an overview of the Typhoid Fever pipeline landscape. The report provides comprehensive information on the therapeutics under development for Typhoid Fever, complete with analysis by stage of development, drug target, me... -
$2,000 Read More Lyme Disease – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Lyme Disease - Pipeline Review, H1 2016’, provides an overview of the Lyme Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Lyme Disease, complete with analysis by stage of development, drug target, mecha... -
$2,000 Read More Bacterial Vaginosis – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Bacterial Vaginosis - Pipeline Review, H1 2016’, provides an overview of the Bacterial Vaginosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Bacterial Vaginosis, complete with analysis by stage of developmen... -
$2,000 Read More Ragweed Allergy – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Ragweed Allergy - Pipeline Review, H1 2016’, provides an overview of the Ragweed Allergy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Ragweed Allergy, complete with analysis by stage of development, drug targ... -
$2,000 Read More Birch Pollen Allergy – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Birch Pollen Allergy - Pipeline Review, H1 2016’, provides an overview of the Birch Pollen Allergy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Birch Pollen Allergy, complete with analysis by stage of develop... -
Read More Diabetic Neuropathic Pain – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Diabetic Neuropathic Pain - Pipeline Review, H1 2016’, provides an overview of the Diabetic Neuropathic Pain pipeline landscape. The report provides comprehensive information on the therapeutics under development for Diabetic Neuropathic Pain, complete with analysis by s... -
$2,000 Read More House Dust Mite Allergy – Pipeline Review, H1 2016
Global Markets Direct’s, ‘House Dust Mite Allergy - Pipeline Review, H1 2016’, provides an overview of the House Dust Mite Allergy pipeline landscape. The report provides comprehensive information on the therapeutics under development for House Dust Mite Allergy, complete with analysis by stage o... -
$2,000 Read More Iron Deficiency Anemia – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Iron Deficiency Anemia - Pipeline Review, H1 2016’, provides an overview of the Iron Deficiency Anemia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Iron Deficiency Anemia, complete with analysis by stage of d...
Sorry, there is no ad related to this category!
-
$1,500 Read More Generon (Shanghai) Corporation Ltd. – Product Pipeline Review – 2015
Global Markets Direct’s, ‘Generon (Shanghai) Corporation Ltd. – Product Pipeline Review – 2015’, provides an […]
-
$2,000 Read More Functional (Non Ulcer) Dyspepsia – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Functional (Non Ulcer) Dyspepsia – Pipeline Review, H1 2016’, provides an overview […]
-
$2,000 Read More Non Alcoholic Fatty Liver Disease (NAFLD) – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Non Alcoholic Fatty Liver Disease (NAFLD) – Pipeline Review, H1 2016’, provides […]
-
$2,500 Read More Bronchospasm Global Clinical Trials Review, H1, 2016
This report provides top line data relating to the clinical trials on Bronchospasm. Report includes […]
-
$6,995 Read More Frontier Pharma: Parkinson’s Disease – Identifying and Commercializing F...
Parkinson’s Disease (PD) is the second most common neurodegenerative disease after Alzheimer’s disease, affecting around […]
-
$1,500 Read More Vaxeal Holding SA – Product Pipeline Review – 2015
Global Markets Direct’s, ‘Vaxeal Holding SA – Product Pipeline Review – 2015’, provides an overview […]
-
$2,000 Read More Lyme Disease – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Lyme Disease – Pipeline Review, H1 2016’, provides an overview of the […]
-
$2,000 Read More Amyloidosis – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Amyloidosis – Pipeline Review, H1 2016’, provides an overview of the Amyloidosis […]
-
$6,995 Read More Frontier Pharma: Versatile Innovation in Oncology – Identifying and Commer...
The oncology therapy area comprises a large and diverse range of indications, encompassing virtually all […]
-
$2,000 Read More Cerebral Palsy – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Cerebral Palsy – Pipeline Review, H1 2016’, provides an overview of the […]
